The Schelin Catheter™ introduced in conjunction with yet another treatment method
Kurs & Likviditet
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
This week, Schelin Catheter™ was successfully used at Guy's Hospital in London, UK for yet another minimally invasive method of treating benign prostatic hyperplasia (BPE). Two patients who underwent treatments with UroLift® System (Registered trademark of Teleflex® and its subsidiary NeoTract® Inc.) received intraprostatic local anesthesia through ProstaLund's injection device prior to treatments.
The Schelin Catheter™ has been used for many years as standard before thermotherapy with ProstaLund's own method CoreTherm®. Then local anesthesia with adrenaline in the prostate is administered with the help of the catheter, which contributes to a substantial painless treatment and a reduced blood flow in the prostate, which in turn has shortened the thermotherapy to today's approximately 10-15 minutes. With the Schelin Catheter™, the prostate can be effectively anesthetized in an easy and sterile way.
"Earlier this year, there has been world premieres for the use of the Schelin Catheter™ in conjunction with water vapor therapy and green laser surgery. The fact that we have now shown that the Schelin Catheter™ can be used for another method shows the potential that our product possesses. The great interest in our product is due to the fact that the clinic can move prostate treatments from resource-intensive operating theaters to an outpatient setting and thus make great savings in the form of human resources, beds and money. At the same time, the patient does not need to have general anesthesia or be sedated and can thus go home immediately after treatment. ", says CEO Johan Wennerholm in a comment.